Skip to main content
Top
Published in: Systematic Reviews 1/2012

Open Access 01-12-2012 | Protocol

Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol

Authors: Matthew M Young, Adrienne Stevens, Amy Porath-Waller, Tyler Pirie, Chantelle Garritty, Becky Skidmore, Lucy Turner, Cheryl Arratoon, Nancy Haley, Karen Leslie, Rhoda Reardon, Beth Sproule, Jeremy Grimshaw, David Moher

Published in: Systematic Reviews | Issue 1/2012

Login to get access

Abstract

Background

There is a significant public health burden associated with substance use in Canada. The early detection and/or treatment of risky substance use has the potential to dramatically improve outcomes for those who experience harms from the non-medical use of psychoactive substances, particularly adolescents whose brains are still undergoing development. The Screening, Brief Intervention, and Referral to Treatment model is a comprehensive, integrated approach for the delivery of early intervention and treatment services for individuals experiencing substance use-related harms, as well as those who are at risk of experiencing such harm.

Methods

This article describes the protocol for a systematic review of the effectiveness of brief interventions as part of the Screening, Brief Intervention, and Referral to Treatment model for reducing the non-medical use of psychoactive substances. Studies will be selected in which brief interventions target non-medical psychoactive substance use (excluding alcohol, nicotine, or caffeine) among those 12 years and older who are opportunistically screened and deemed at risk of harms related to psychoactive substance use. We will include one-on-one verbal interventions and exclude non-verbal brief interventions (for example, the provision of information such as a pamphlet or online interventions) and group interventions. Primary, secondary and adverse outcomes of interest are prespecified. Randomized controlled trials will be included; non-randomized controlled trials, controlled before-after studies and interrupted time series designs will be considered in the absence of randomized controlled trials. We will search several bibliographic databases (for example, MEDLINE, EMBASE, CINAHL, PsycINFO, CORK) and search sources for grey literature. We will meta-analyze studies where possible. We will conduct subgroup analyses, if possible, according to drug class and intervention setting.

Discussion

This review will provide evidence on the effectiveness of brief interventions as part of the Screening, Brief Intervention, and Referral to Treatment protocol aimed at the non-medical use of psychoactive substances and may provide guidance as to where future research might be most beneficial.
Literature
1.
go back to reference Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L: Reporting Guidelines for Systematic Review Protocols. 2011, Madrid, Spain:In 19th Cochrane Colloquium: October 19–22 2011 Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L: Reporting Guidelines for Systematic Review Protocols. 2011, Madrid, Spain:In 19th Cochrane Colloquium: October 19–22 2011
3.
go back to reference Rehm J, Baliunas D, Brochu S, Fischer B, Gnam W, Patra J, Popova S, Sarnocinska-Hart A, Taylor B: The costs of substance abuse in Canada 2002. 2006, Canadian Centre on Substance Abuse, Ottawa, ON Rehm J, Baliunas D, Brochu S, Fischer B, Gnam W, Patra J, Popova S, Sarnocinska-Hart A, Taylor B: The costs of substance abuse in Canada 2002. 2006, Canadian Centre on Substance Abuse, Ottawa, ON
4.
go back to reference Degenhardt L, Hall W, Warner-Smith M, Lynskey M: Illicit drug use. Global and regional burden of diseases attributable to selected major risk factors. Edited by: Ezzati M, Lopez AD, Rogers A, Murray CJL. 2004, World Health Organization, Geneva, 1 Degenhardt L, Hall W, Warner-Smith M, Lynskey M: Illicit drug use. Global and regional burden of diseases attributable to selected major risk factors. Edited by: Ezzati M, Lopez AD, Rogers A, Murray CJL. 2004, World Health Organization, Geneva, 1
5.
go back to reference Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J: Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007, 28 (3): 7-30. 10.1300/J465v28n03_03.CrossRefPubMed Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J: Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007, 28 (3): 7-30. 10.1300/J465v28n03_03.CrossRefPubMed
6.
go back to reference Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Part II. Addiction. 1993, 88: 791-804. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Part II. Addiction. 1993, 88: 791-804.
7.
go back to reference Adamson SJ, Sellman JD: A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev. 2003, 22 (3): 309-315. 10.1080/0959523031000154454.CrossRefPubMed Adamson SJ, Sellman JD: A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev. 2003, 22 (3): 309-315. 10.1080/0959523031000154454.CrossRefPubMed
8.
go back to reference Webster LR, Webster RM: Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005, 6 (6): 432-442. 10.1111/j.1526-4637.2005.00072.x.CrossRefPubMed Webster LR, Webster RM: Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005, 6 (6): 432-442. 10.1111/j.1526-4637.2005.00072.x.CrossRefPubMed
9.
go back to reference Gavin DR, Ross HE, Skinner HA: Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict. 1989, 84 (3): 301-307. 10.1111/j.1360-0443.1989.tb03463.x.CrossRefPubMed Gavin DR, Ross HE, Skinner HA: Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict. 1989, 84 (3): 301-307. 10.1111/j.1360-0443.1989.tb03463.x.CrossRefPubMed
10.
go back to reference Carney T, Myers BJ, Louw J: Brief school-based interventions and behavioural outcomes for substance-using adolescents. Cochrane Database Syst Rev. 2011, 2: CD008969- Carney T, Myers BJ, Louw J: Brief school-based interventions and behavioural outcomes for substance-using adolescents. Cochrane Database Syst Rev. 2011, 2: CD008969-
11.
go back to reference Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, Heather N, Saunders J, Burnand B: Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007, 2: CD004148-PubMed Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, Heather N, Saunders J, Burnand B: Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007, 2: CD004148-PubMed
12.
go back to reference McQueen J, Howe TE, Allan L, Mains D, Hardy V: Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2011, 8: CD005191-PubMed McQueen J, Howe TE, Allan L, Mains D, Hardy V: Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2011, 8: CD005191-PubMed
13.
go back to reference Levy S, Vaughan BL, Knight JR: Office-based intervention for adolescent substance abuse. Pediatr Clin N Am. 2002, 49 (2): 329-343. 10.1016/S0031-3955(01)00007-4.CrossRef Levy S, Vaughan BL, Knight JR: Office-based intervention for adolescent substance abuse. Pediatr Clin N Am. 2002, 49 (2): 329-343. 10.1016/S0031-3955(01)00007-4.CrossRef
14.
go back to reference Kahan M, Wilson L, Becker L: Effectiveness of physician-based interventions with problem drinkers: a review. Canadian Med Assoc J. 1995, 152 (6): 851-859. Kahan M, Wilson L, Becker L: Effectiveness of physician-based interventions with problem drinkers: a review. Canadian Med Assoc J. 1995, 152 (6): 851-859.
15.
go back to reference Reid MC, Fiellin DA, O'Connor PG: Hazardous and harmful alcohol consumption in primary care. Arch Intern Med. 1999, 159 (15): 1681-1689. 10.1001/archinte.159.15.1681.CrossRefPubMed Reid MC, Fiellin DA, O'Connor PG: Hazardous and harmful alcohol consumption in primary care. Arch Intern Med. 1999, 159 (15): 1681-1689. 10.1001/archinte.159.15.1681.CrossRefPubMed
16.
go back to reference Wilk AI, Jensen NM, Havighurst TC: Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Int Med. 1997, 12 (5): 274-283. 10.1007/s11606-006-5063-z.CrossRef Wilk AI, Jensen NM, Havighurst TC: Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Int Med. 1997, 12 (5): 274-283. 10.1007/s11606-006-5063-z.CrossRef
17.
go back to reference Copeland J, Swift W, Roffman R, Stephens R: A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abus Treat. 2001, 21 (2): 55-64. 10.1016/S0740-5472(01)00179-9.CrossRef Copeland J, Swift W, Roffman R, Stephens R: A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abus Treat. 2001, 21 (2): 55-64. 10.1016/S0740-5472(01)00179-9.CrossRef
18.
go back to reference Humeniuk R, Ali R, Babor T, Souza-Formigoni ML, de Lacerda RB, Ling W, McRee B, Newcombe D, Pal H, Poznyak V, Simon S, Vendetti J: A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health care settings in four countries. Addiction. 2012, 107 (5): 957-966. 10.1111/j.1360-0443.2011.03740.x.CrossRefPubMed Humeniuk R, Ali R, Babor T, Souza-Formigoni ML, de Lacerda RB, Ling W, McRee B, Newcombe D, Pal H, Poznyak V, Simon S, Vendetti J: A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health care settings in four countries. Addiction. 2012, 107 (5): 957-966. 10.1111/j.1360-0443.2011.03740.x.CrossRefPubMed
19.
go back to reference Lang E, Engelander M, Brooke T: Report of an integrated brief intervention with self-defined problem cannabis users. J Subst Abus Treat. 2000, 19 (2): 111-116. 10.1016/S0740-5472(99)00104-X.CrossRef Lang E, Engelander M, Brooke T: Report of an integrated brief intervention with self-defined problem cannabis users. J Subst Abus Treat. 2000, 19 (2): 111-116. 10.1016/S0740-5472(99)00104-X.CrossRef
20.
go back to reference Martin G, Copeland J, Swift W: The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users. J Subst Abus Treat. 2005, 29 (3): 207-213. 10.1016/j.jsat.2005.06.005.CrossRef Martin G, Copeland J, Swift W: The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users. J Subst Abus Treat. 2005, 29 (3): 207-213. 10.1016/j.jsat.2005.06.005.CrossRef
21.
go back to reference McCambridge J, Strang J: The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction. 2004, 99 (1): 39-52. 10.1111/j.1360-0443.2004.00564.x.CrossRefPubMed McCambridge J, Strang J: The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction. 2004, 99 (1): 39-52. 10.1111/j.1360-0443.2004.00564.x.CrossRefPubMed
22.
go back to reference Martin G, Copeland J: Brief intervention for regular ecstasy (MDMA) user: pilot randomized trial of a Check-Up model. J Subs Use. 2010, 15 (2): 131-142. 10.3109/14659890903075074.CrossRef Martin G, Copeland J: Brief intervention for regular ecstasy (MDMA) user: pilot randomized trial of a Check-Up model. J Subs Use. 2010, 15 (2): 131-142. 10.3109/14659890903075074.CrossRef
23.
go back to reference Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R: Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005, 77 (1): 49-59. 10.1016/j.drugalcdep.2004.07.006.CrossRefPubMed Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R: Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005, 77 (1): 49-59. 10.1016/j.drugalcdep.2004.07.006.CrossRefPubMed
24.
go back to reference Stotts AL, Schmitz JM, Rhoades HM, Grabowski J: Motivational interviewing with cocaine-dependent patients: a pilot study. J Consult Clin Psychol. 2001, 69 (5): 858-862.CrossRefPubMed Stotts AL, Schmitz JM, Rhoades HM, Grabowski J: Motivational interviewing with cocaine-dependent patients: a pilot study. J Consult Clin Psychol. 2001, 69 (5): 858-862.CrossRefPubMed
25.
go back to reference Bashir K, King M, Ashworth M: Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994, 44 (386): 408-412.PubMedPubMedCentral Bashir K, King M, Ashworth M: Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract. 1994, 44 (386): 408-412.PubMedPubMedCentral
26.
go back to reference Saitz R, Alford DP, Bernstein J, Cheng DM, Samet J, Palfai T: Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J Addiction Med. 2010, 4 (3): 123-130. 10.1097/ADM.0b013e3181db6b67.CrossRef Saitz R, Alford DP, Bernstein J, Cheng DM, Samet J, Palfai T: Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J Addiction Med. 2010, 4 (3): 123-130. 10.1097/ADM.0b013e3181db6b67.CrossRef
27.
go back to reference Walker DD, Roffman RA, Stephens RS, Wakana K, Berghuis J, Kim W: Motivational enhancement therapy for adolescent marijuana users: a preliminary randomized controlled trial. J Consult Clin Psychol. 2006, 74 (3): 628-632.CrossRefPubMedPubMedCentral Walker DD, Roffman RA, Stephens RS, Wakana K, Berghuis J, Kim W: Motivational enhancement therapy for adolescent marijuana users: a preliminary randomized controlled trial. J Consult Clin Psychol. 2006, 74 (3): 628-632.CrossRefPubMedPubMedCentral
28.
go back to reference McCabe SE, Cranford JA, West BT: Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav. 2008, 33 (10): 1297-1305. 10.1016/j.addbeh.2008.06.005.CrossRefPubMedPubMedCentral McCabe SE, Cranford JA, West BT: Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav. 2008, 33 (10): 1297-1305. 10.1016/j.addbeh.2008.06.005.CrossRefPubMedPubMedCentral
30.
go back to reference Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J: PRESS: Peer Review of Electronic Search Strategies. 2008, Canadian Agency for Drugs and Technologies in Health, Ottawa, ON Sampson M, McGowan J, Lefebvre C, Moher D, Grimshaw J: PRESS: Peer Review of Electronic Search Strategies. 2008, Canadian Agency for Drugs and Technologies in Health, Ottawa, ON
32.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151 (4): 264-269. W264CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151 (4): 264-269. W264CrossRefPubMed
33.
go back to reference Reeves BC, Deeks JJ, Higgins JPT, Wells GA, Higgins JPT, Altman DG, Sterne JAC, the Cochrane Non-Randomised Studies Methods Group, the Cochrane Non-Randomised Studies Methods Group: Chapter 13.5: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration, http://www.cochrane-handbook.org Reeves BC, Deeks JJ, Higgins JPT, Wells GA, Higgins JPT, Altman DG, Sterne JAC, the Cochrane Non-Randomised Studies Methods Group, the Cochrane Non-Randomised Studies Methods Group: Chapter 13.5: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration, http://​www.​cochrane-handbook.​org
34.
go back to reference Higgins JPT, Deeks JJ, Altman DG: Chapter 16: Special topics in statistics. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration,http://www.cochrane-handbook.org, Higgins JPT, Deeks JJ, Altman DG: Chapter 16: Special topics in statistics. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration,http://​www.​cochrane-handbook.​org,
35.
go back to reference Killip S, Mahfoud Z, Pearce K: What is an intracluster correlation coefficient? Crucial concepts for primary care researchers. Ann Fam Med. 2004, 2 (3): 204-208. 10.1370/afm.141.CrossRefPubMedPubMedCentral Killip S, Mahfoud Z, Pearce K: What is an intracluster correlation coefficient? Crucial concepts for primary care researchers. Ann Fam Med. 2004, 2 (3): 204-208. 10.1370/afm.141.CrossRefPubMedPubMedCentral
36.
go back to reference Deeks JJ, Higgins JPT, Altman DG: Chapter 9: Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration Deeks JJ, Higgins JPT, Altman DG: Chapter 9: Analysing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration
37.
go back to reference Parmar MK, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statis Med. 1998, 17 (24): 2815-2834. 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8.CrossRef Parmar MK, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statis Med. 1998, 17 (24): 2815-2834. 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8.CrossRef
38.
go back to reference Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE: Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care. 2003, 19 (4): 613-623.CrossRefPubMed Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE: Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care. 2003, 19 (4): 613-623.CrossRefPubMed
39.
go back to reference Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011, 343: d4002-10.1136/bmj.d4002.CrossRefPubMed Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011, 343: d4002-10.1136/bmj.d4002.CrossRefPubMed
40.
go back to reference Sterne JAC, Egger M, Moher D: Chapter 10: Addressing reporting biases. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration,http://www.cochrane-handbook.org, Sterne JAC, Egger M, Moher D: Chapter 10: Addressing reporting biases. Cochrane Handbook for Systematic Reviews of Interventions. Volume 5.10. Edited by: Higgins JPT, Green S. 2011, The Cochrane Collaboration,http://​www.​cochrane-handbook.​org,
42.
go back to reference Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM: Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007, 7: 10-10.1186/1471-2288-7-10.CrossRefPubMedPubMedCentral Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM: Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007, 7: 10-10.1186/1471-2288-7-10.CrossRefPubMedPubMedCentral
43.
go back to reference Garritty C, Ansari M, Yazdi F, Singh K, Galipeau J, Pratt M, Young MM, Skidmore R, Lal A, Daniel R, Moher D, Grimshaw J: Evidence map of systematic reviews to inform the prevention, treatment, and/or harm reduction for illicit drug use. Report submitted to the Institute of Neuroscience, Addiction & Mental Health (INMHA). Canadian Institutes Health Res (CIHR). 2011,www.ohri.ca/ksgroup/publications.asp, Garritty C, Ansari M, Yazdi F, Singh K, Galipeau J, Pratt M, Young MM, Skidmore R, Lal A, Daniel R, Moher D, Grimshaw J: Evidence map of systematic reviews to inform the prevention, treatment, and/or harm reduction for illicit drug use. Report submitted to the Institute of Neuroscience, Addiction & Mental Health (INMHA). Canadian Institutes Health Res (CIHR). 2011,www.​ohri.​ca/​ksgroup/​publications.​asp,
Metadata
Title
Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol
Authors
Matthew M Young
Adrienne Stevens
Amy Porath-Waller
Tyler Pirie
Chantelle Garritty
Becky Skidmore
Lucy Turner
Cheryl Arratoon
Nancy Haley
Karen Leslie
Rhoda Reardon
Beth Sproule
Jeremy Grimshaw
David Moher
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2012
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/2046-4053-1-22

Other articles of this Issue 1/2012

Systematic Reviews 1/2012 Go to the issue